The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Medical Progress
PreviousPrevious
Volume 354:1281-1293 March 23, 2006 Number 12
NextNext

Pregnancy in Recipients of Solid Organs — Effects on Mother and Child
Dianne B. McKay, M.D., and Michelle A. Josephson, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
The first child born to a transplant recipient turned 48 years old on March 10, 2006.1 When the field of transplantation was first developing, physicians worried about the teratogenicity of immunosuppressive medications2 and considered pregnancy ill-advised.3,4 Despite early concerns, approximately 14,000 births among women with transplanted organs have been reported worldwide,5 and many more have assuredly occurred. Pregnancy is now an expected part of the benefits afforded to women by organ transplantation.

However, substantial gaps remain in our knowledge about pregnancy in the transplant recipient and its effects on the child. As discussed in an article by Ross that appears . . . [Full Text of this Article]

Sources of Information about Pregnancy in Transplant Recipients

Fertility, End-Stage Disease, and Transplantation

Optimal Timing of Pregnancy after Transplantation

Risk of Pregnancy Complications in the Transplant Recipient

            Hypertension and Preeclampsia in Pregnant Kidney-Transplant Recipients

            Hypertension and Preeclampsia in Pregnant Recipients of Other Solid-Organ Transplants

            Risk of Allograft Loss

            Pregnancy and the Risk of Rejection

Immunosuppressive Medications and the Maternal–Fetal Circulation

Immunosuppressive Medications and the Fetus

Toxic Effects of Immunosuppressive Agents in Pregnancy

Structural Malformations in Animal Models

Structural Malformations in Children of Transplant Recipients

            Drug-Induced Immunologic Abnormalities in the Fetus and Newborn

Long-Term Consequences of in Utero Exposure to Immunosuppressive Medications

Breast-Feeding by Mothers Receiving Immunosuppressive Medication

Conclusions


Source Information

From the Department of Immunology, Scripps Research Institute, La Jolla, Calif. (D.B.M.); and the Department of Medicine, Section of Nephrology, University of Chicago, Chicago (M.A.J.).

Address reprint requests to Dr. McKay at the Department of Immunology, Scripps Research Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037, or at dmckay@scripps.edu.


Related Letters:

Pregnancy in Recipients of Solid-Organ Transplants
Padhan P., McKay D. B., Josephson M. A.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:2726-2727, Jun 22, 2006. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.